Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.94 USD | +0.92% | -2.36% | -24.68% |
Jun. 03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
Jun. 03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.68% | 2.19B | |
+48.07% | 57.87B | |
+41.65% | 40.25B | |
-7.02% | 39.94B | |
-5.96% | 28.54B | |
+12.14% | 26.4B | |
-20.70% | 19.33B | |
+30.11% | 12.4B | |
-0.82% | 12.23B | |
+24.43% | 12.2B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals